Product Code: SR1623A119_Report
Market Overview:
The global artificial intelligence in healthcare market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 23.9 Billion by 2028, exhibiting a growth rate (CAGR) of 29.8% during 2023-2028.
Artificial intelligence (AI) in healthcare is utilized for managing and analyzing data for performing clinical diagnosis and suggesting appropriate treatment plans for an ailment. It uses various software and sophisticated algorithms to evaluate symptoms and patterns of diseases while providing better guidance, feedback and support to the healthcare providers. Apart from this, systems equipped with AI can provide digital and virtual consultations to patients, offer drug creation and management facilities, and healthcare analysis through smart wearable devices.
Artificial Intelligence in Healthcare Market Trends:
The increasing utilization of robots for surgical and rehabilitation procedures in the healthcare industry is one of the key factors driving the growth of the market. Robots can efficiently conduct minimally invasive (MI) surgeries for neurologic, orthopedic and laparoscopic procedures. Furthermore, the emerging trend of digitalization in the healthcare sector is also providing a boost to the market. Various medical devices and systems are being equipped with AI for convenient and secure management of data. This further aids in generating patient-specific information which is utilized for providing personalized diagnostic and pharmaceutical services. The market is also being driven by the rising geriatric population and their increasing dependence on healthcare services. AI is largely being integrated into elderly care products, such as smart devices for assisted living, fall detection and virtual companions. These empathic robots can also provide care to physically and mentally challenged patients, while industrial robots are used to perform various routine tasks in healthcare centers. Other factors, including enhanced research and development (R&D), along with favorable healthcare policies by governments of several nations, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial intelligence in healthcare market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on offering, technology, application and end-user.
Breakup by Offering:
- Hardware
- Software
- Services
Breakup by Technology:
- Machine Learning
- Context-Aware Computing
- Natural Language Processing
- Others
Breakup by Application:
- Robot-Assisted Surgery
- Virtual Nursing Assistant
- Administrative Workflow Assistance
- Fraud Detection
- Dosage Error Reduction
- Clinical Trial Participant Identifier
- Preliminary Diagnosis
- Others
Breakup by End-User:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Patients
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Amazon Web Services Inc., Cloudmedx Inc., DeepMind, Enlitic Inc., General Vision Inc., Google Inc., International Business Machines, iCarbonX, Intel Corporation, Medtronic, Micron Technology Inc., Microsoft Corporation, Next It Corporation, Nuance Communications Inc., Nvidia Corporation, Siemens Healthcare, Welltok Inc., etc.
Key Questions Answered in This Report:
- What was the size of the global artificial intelligence in healthcare market in 2022?
- What is the expected growth rate of the global artificial intelligence in healthcare market during 2023-2028?
- What has been the impact of COVID-19 on the global artificial intelligence in healthcare market?
- What are the key factors driving the global artificial intelligence in healthcare market?
- What is the breakup of the global artificial intelligence in healthcare market based on the offering?
- What is the breakup of the global artificial intelligence in healthcare market based on the technology?
- What is the breakup of the global artificial intelligence in healthcare market based on the application?
- What is the breakup of the global artificial intelligence in healthcare market based on the end-user?
- What are the key regions in the global artificial intelligence in healthcare market?
- Who are the key players/companies in the global artificial intelligence in healthcare market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Artificial Intelligence in Healthcare Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Offering
- 6.1 Hardware
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Software
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Machine Learning
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Context Aware Computing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Natural Language Processing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Robot-Assisted Surgery
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Virtual Nursing Assistant
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Administrative Workflow Assistance
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Fraud Detection
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Dosage Error Reduction
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Clinical Trial Participant Identifier
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Preliminary Diagnosis
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Healthcare Providers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Patients
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Amazon Web Services Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.2 Cloudmedx Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 DeepMind
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Enlitic Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 General Vision Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Google Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 International Business Machines
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 iCarbonX
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Intel Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Medtronic
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Micron Technology Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Microsoft Corporation
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Next It Corporation
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.14 Nuance Communications Inc.
- 15.3.14.1 Company Overview
- 15.3.14.2 Product Portfolio
- 15.3.14.3 Financials
- 15.3.14.4 SWOT Analysis
- 15.3.15 Nvidia Corporation
- 15.3.15.1 Company Overview
- 15.3.15.2 Product Portfolio
- 15.3.15.3 Financials
- 15.3.15.4 SWOT Analysis
- 15.3.16 Siemens Healthcare
- 15.3.16.1 Company Overview
- 15.3.16.2 Product Portfolio
- 15.3.16.3 Financials
- 15.3.16.4 SWOT Analysis
- 15.3.17 Welltok Inc.
- 15.3.17.1 Company Overview
- 15.3.17.2 Product Portfolio